Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine?

Burke W, Burton H, Hall AE, Karmali M, Khoury MJ, Knoppers B, Meslin EM, Stanley F, Wright CF, Zimmern RL; Ickworth Group.

Genet Med. 2010 Dec;12(12):785-91. doi: 10.1097/GIM.0b013e3182011222.

PMID:
21189494
2.

Will genomics widen or help heal the schism between medicine and public health?

Khoury MJ, Gwinn M, Burke W, Bowen S, Zimmern R.

Am J Prev Med. 2007 Oct;33(4):310-7.

PMID:
17888858
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Advancing the post-genomic era agenda: contributions from public health.

McGrath BB.

Public Health Genomics. 2012;15(3-4):125-31. doi: 10.1159/000335551. Epub 2012 Apr 4.

PMID:
22488454
5.

The public health genomics translation gap: what we don't have and why it matters.

Williams MS.

Public Health Genomics. 2012;15(3-4):132-8. doi: 10.1159/000334341. Epub 2012 Apr 4.

PMID:
22488455
6.

Public Health Genomics and personalized healthcare: a pipeline from cell to society.

Brand A.

Drug Metabol Drug Interact. 2012;27(3):121-3. doi: 10.1515/dmdi-2012-0028. No abstract available.

PMID:
23104820
7.

Role of genomics on the path to personalized medicine.

Tremblay J, Hamet P.

Metabolism. 2013 Jan;62 Suppl 1:S2-5. doi: 10.1016/j.metabol.2012.08.023. Epub 2012 Sep 25.

PMID:
23021037
8.

Overview of personalized medicine in the disease genomic era.

Hong KW, Oh B.

BMB Rep. 2010 Oct;43(10):643-8. doi: 10.5483/BMBRep.2010.43.10.643. Review.

9.
10.

Translating genomics in cancer care.

Bombard Y, Bach PB, Offit K.

J Natl Compr Canc Netw. 2013 Nov;11(11):1343-53. Review.

PMID:
24225968
11.

Expert Group Meeting on Family Planning, Health and Family Well-Being.

[No authors listed]

Popul Bull UN. 1993;(34-35):79-101.

PMID:
12287717
12.

Emerging landscape of genomics in the Electronic Health Record for personalized medicine.

Ullman-Cullere MH, Mathew JP.

Hum Mutat. 2011 May;32(5):512-6. doi: 10.1002/humu.21456. Epub 2011 Mar 10.

PMID:
21309042
13.

The First National Pain Medicine Summit--final summary report.

Lippe PM, Brock C, David J, Crossno R, Gitlow S.

Pain Med. 2010 Oct;11(10):1447-68. doi: 10.1111/j.1526-4637.2010.00961.x.

PMID:
21199301
14.

Genomic and personalized medicine: foundations and applications.

Ginsburg GS, Willard HF.

Transl Res. 2009 Dec;154(6):277-87. doi: 10.1016/j.trsl.2009.09.005. Epub 2009 Oct 1. Review.

PMID:
19931193
15.

The contribution of health technology assessment, health needs assessment, and health impact assessment to the assessment and translation of technologies in the field of public health genomics.

Rosenkötter N, Vondeling H, Blancquaert I, Mekel OC, Kristensen FB, Brand A.

Public Health Genomics. 2011;14(1):43-52. doi: 10.1159/000318317. Epub 2010 Oct 8. Review.

PMID:
20926845
16.

Investigative pathology: leading the post-genomic revolution.

Berman DM, Bosenberg MW, Orwant RL, Thurberg BL, Draetta GF, Fletcher CD, Loda M.

Lab Invest. 2012 Jan;92(1):4-8. doi: 10.1038/labinvest.2011.147. Epub 2011 Oct 10. Review.

17.
18.

The health benefits of genomics: out with the old, in with the new.

Hudson K.

Health Aff (Millwood). 2008 Nov-Dec;27(6):1612-5. doi: 10.1377/hlthaff.27.6.1612.

PMID:
18997218
19.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

20.

Proceedings for the 5th Asia-Pacific Conference on Disaster Medicine: creating an agenda for action.

De Grace M, Ericson D, Folz H, Greene W, Ho K, Pearce L.

Prehosp Disaster Med. 2001 Jan-Mar;16(1):18-21.

PMID:
11367932

Supplemental Content

Support Center